FDA Clears NeuroOne Evo sEEG Device for Use Up to 30 Days
The U.S. Food and Drug Administration (FDA) has granted NeuroOne Medical Technologies clearance to market its Evo stereoelectroencephalography (sEEG)…
Articles by Marisa Wexler, MS
Human Embryonic Stem Cell Therapies Viewed Favorably: Survey
People with Parkinson’s disease have generally positive attitudes toward using therapies derived from human embryos, according to a new…
Neurorehabilitation Seen to Ease Disease Symptoms, Protect Neurons
A therapeutic mix of exercise, cognitive stimulation and social activity — known as environmental enrichment — eased Parkinson’s disease symptoms…
Former Parkinson’s Caregivers Could Help Those Now in That Role
Former caregivers could serve as a helpful resource in supporting current caregivers of people with Parkinson’s disease, a study…
Potential Therapy FB-101 Well-tolerated in Healthy Volunteers
FB-101, an experimental oral therapy that 1ST Biotherapeutics is developing as a treatment for Parkinson’s disease, was well-tolerated…
Stem Cell-derived Therapy Eases Motor Deficits in Parkinson’s Model
A transplant of stem cell-derived nerve cells engineered to produce a signaling factor that promotes nerve health was shown to…
Faster Progression Found in ‘Body-involvement’ Parkinson’s in Study
People with Parkinson’s disease who show early dysfunction in the nerves controlling heartbeat tend to experience faster disease progression,…
Ventus, Novo Nordisk Partner on Anti-inflammatory Medications
Ventus Therapeutics and Novo Nordisk have agreed to work together to develop new anti-inflammatory medicines that may be…
Pisa Syndrome in Parkinson’s Tied to Visual/Balance Processing Problems
Parkinson’s patients with a postural abnormality called Pisa syndrome show deficits in their ability to process visual and…
Zonisamide for Epilepsy May Ease Parkinson’s Motor Symptoms: Study
Zonisamide, an epilepsy medication approved in the U.S. for some seizure-causing disorders, may reduce the motor symptoms of Parkinson’s…